Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy

Overexpression of ErbB-2/HER2 is associated with aggressive human malignancies, and therapeutic strategies targeting the oncoprotein are currently in different stages of clinical application. Tyrosine kinase inhibitors (TKIs) that block the nucleotide-binding site of the kinase are especially effect...

ver descrição completa

Detalhes bibliográficos

Publicado no:	EMBO J
Principais autores:	Citri, Ami, Alroy, Iris, Lavi, Sara, Rubin, Chanan, Xu, Wanping, Grammatikakis, Nicolas, Patterson, Cam, Neckers, Len, Fry, David W., Yarden, Yosef
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Publishing Group 2002
Assuntos:	Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC126014/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12006493/ https://ncbi.nlm.nih.govhttps://doi.org/10.1093/emboj/21.10.2407
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!